Make your Hepatic Research Robust with Vevo Ultra-High Frequency (UHF) Ultrasound Imaging

Vevo 4 Series: Liver & NASH/Kidney | FUJIFILM VisualSonics

With the Vevo UHF imaging systems you can delineate organs, abnormalities, and tumors with high resolution.

Users can also assess functionality within the liver using the Color and PW Doppler (assess blood flow velocity) and 3D tools.

Watch Liver & Nash video On Demand.

How Can the Ultra-High Frequency Ultrasound Help You?

Non-invasive, pre-palpable tumor identification
Liver/tumor perfusion and volume quantification
Contrast-enhanced imaging of biomarkers
Assess and quantify oxygenation/hypoxia

Great for:

Liver metastasis models
Liver Cirrhosis (obtain channel/RF data for offline development)
Non-alcoholic fatty liver disease
Non-alcoholic steatohepatitis (NASH)

Recorded Webinar

Ultrasound of Liver Fibrosis & Hepatocellular Carcinoma

Presenter: Laith Sultan, Post Doctoral Fellow in the Department of Radiology Ultrasound Research Lab at the University of Pennsylvania.

Includes the following and more:
- Multiparametric quantitative B-Mode ultrasound for monitoring liver fibrosis
- Quantitative multimodality assessment of Antivascular Ultrasound (AVUS) therapy for hepatocellular carcinoma (HCC)

Recorded Webinar

Quantitative Ultrasound and Photoacoustic Imaging of Liver Fibrosis

Presented by Laith R. Sultan MD MPH and Mrigendra B. Karmacharya PhD from the PENN Ultrasound Lab at the University of Pennsylvania, on March 11th, 2021.

Includes the following and more:

Liver fibrosis as public and global health issue
The advantages and disadvantages of the current imaging and non-imaging diagnostic tools of liver fibrosis.